
    
      Two topical NSAIDs currently approved for postoperative treatment of pain and inflammation in
      cataract surgery are bromfenac 0.09% and nepafenac 0.1%. Both purport to treat ocular
      inflammation by acting as a potent inhibitor of COX-1 and COX-2 enzymes. Clinical studies to
      date lack clarity on which topical NSAID may be the most efficacious.
    
  